Literature DB >> 19358837

Citrullinemia type I, classical variant. Identification of ASS-p~G390R (c.1168G>A) mutation in families of a limited geographic area of Argentina: a possible population cluster.

Laura E Laróvere1, Celia J Angaroni, Sandra L Antonozzi, Miriam B Bezard, Mariko Shimohama, Raquel Dodelson de Kremer.   

Abstract

OBJECTIVE: Citrullinemia type I (CTLN1) is an urea cycle defect caused by mutations in the argininosuccinate synthetase gene. We report the first identification in Argentina of patients with CTLN1 in a limited geographic area. DESIGN AND METHODS: Molecular analysis in patient/relatives included PCR, sequencing and restriction enzyme assay.
RESULTS: The studied families showed the same mutation: ASS~p.G390R, associated with the early-onset/severe phenotype.
CONCLUSION: We postulate a possible population cluster. A program to know the carrier frequency in that population is in progress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19358837     DOI: 10.1016/j.clinbiochem.2009.03.024

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

1.  Favorable long-term outcome following severe neonatal hyperammonemic coma in a patient with argininosuccinate synthetase deficiency.

Authors:  Isabelle De Bie; Emmanuelle Lemyre; Marie Lambert
Journal:  JIMD Rep       Date:  2011-06-22

2.  Molecular epidemiology of citrullinemia type I in a risk region of Argentina: a first step to preconception heterozygote detection.

Authors:  Laura E Laróvere; Silene M Silvera Ruiz; Celia J Angaroni; Raquel Dodelson de Kremer
Journal:  JIMD Rep       Date:  2012-02-26

Review 3.  Citrullinemia type I is associated with a novel splicing variant, c.773 + 4A > C, in ASS1: a case report and literature review.

Authors:  Yiming Lin; Hongzhi Gao; Bin Lu; Shuang Zhou; Tianwen Zheng; Weihua Lin; Lin Zhu; Mengyi Jiang; Qingliu Fu
Journal:  BMC Med Genet       Date:  2019-06-17       Impact factor: 2.103

4.  Clinical, laboratory data and outcomes of 17 Iranian citrullinemia type 1 patients: Identification of five novel ASS1 gene mutations.

Authors:  Shirin Moarefian; Mahdi Zamani; Ali Rahmanifar; Babak Behnam; Talieh Zaman
Journal:  JIMD Rep       Date:  2022-03-09

5.  Urea cycle disorders in India: clinical course, biochemical and genetic investigations, and prenatal testing.

Authors:  Sunita Bijarnia-Mahay; Johannes Häberle; Anil B Jalan; Ratna Dua Puri; Sudha Kohli; Ketki Kudalkar; Véronique Rüfenacht; Deepti Gupta; Deepshikha Maurya; Jyotsna Verma; Yosuke Shigematsu; Seiji Yamaguchi; Renu Saxena; Ishwar C Verma
Journal:  Orphanet J Rare Dis       Date:  2018-10-01       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.